West Pharmaceutical Services Inc. Stock
There is an upward development for West Pharmaceutical Services Inc. compared to yesterday, with an increase of €3.30 (1.490%).
With 12 Buy predictions and not the single Sell prediction the community is currently very high on West Pharmaceutical Services Inc..
As a result the target price of 297 € shows a positive potential of 32.41% compared to the current price of 224.3 € for West Pharmaceutical Services Inc..
Pros and Cons of West Pharmaceutical Services Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
S********** s********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of West Pharmaceutical Services Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| West Pharmaceutical Services Inc. | 1.490% | 0.000% | 10.060% | 18.977% | -5.676% | -33.454% | -13.807% |
| Haemonetics Corp. | 1.980% | - | - | - | - | - | - |
| Bio-Rad Labs Inc. A | 0.500% | 1.913% | 4.970% | 7.692% | -5.002% | -44.268% | -51.961% |
| CONMED Corp. | -0.610% | 3.333% | -4.321% | -33.476% | -11.429% | -68.367% | -72.321% |
Comments
West Pharmaceutical Services (NYSE:WST) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (NYSE:WST) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services (NYSE:WST) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for WST provided by MarketBeat